M3 Wake Research | Tucson Neuroscience Research

Research site
6567 East Carondelet, Suite 475, Tucson, Arizona, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


8 of 22
Status: Active
Trial type: Interventional
Funder type: Industry

A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease

Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elderly population. Cli...

Alzheimer's Disease (AD)
Drug: Placebo
Drug: ABBV-916

The purpose of this is study is to compare the efficacy of BHV-3500 (zavegepant) to placebo as a preventive treatment for migraine, as measured by th...

Active, not recruiting
Drug: Placebo
Drug: BHV-3500 (zavegepant)

The main purpose of Part A of this study is to evaluate the safety and tolerability of mRNA-1345 vaccine and to demonstrate the efficacy of a single...

Active, not recruiting
Respiratory Syncytial Virus
Drug: mRNA-1345
Drug: Placebo

The primary objectives of this study are to assess the safety, tolerability, and efficacy of ABP-671 in lowering serum uric acid (sUA) in participant...

Drug: ABP-671
Drug: Allopurinol

This is a Phase 2/3, randomized, double-blind study to evaluate the safety and immunogenicity of different booster dose levels of the monovalent seve...

Active, not recruiting
Biological: NVX-CoV2601 (5μg)
Biological: NVX-CoV2601 (35μg)

This is a multicenter, randomized, double-blind, Phase 2b/3 study to evaluate the efficacy and safety of ABP-671. Part 1 of the study will compare th...

Drug: ABP-671
Other: Placebo

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and so...

Active, not recruiting
Episodic Migraine
Drug: Placebo

The purpose of this study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants...

Alzheimer Disease, Early Onset
Other: Placebo
Drug: BMS-986446

Trial conditions

Alzheimer Disease (6 trials)
Migraine Disorders (6 trials)
Parkinson Disease (3 trials)
Dementia (2 trials)
Gout (2 trials)
COVID-19 (1 trial)
Essential Tremor (1 trial)
Frontotemporal Dementia (1 trial)
Glucose Intolerance (1 trial)
Lewy Body Disease (1 trial)

And 11 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems